Bausch Health Companies (BHC) Expected to Announce Earnings on Wednesday

Bausch Health Companies (NYSE:BHC) is expected to be posting its quarterly earnings results after the market closes on Wednesday, February 19th. Analysts expect Bausch Health Companies to post earnings of $1.65 per share and revenue of $2.51 billion for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Bausch Health Companies Stock Performance

BHC opened at $6.15 on Tuesday. The stock has a market capitalization of $2.22 billion, a P/E ratio of -12.82, a P/E/G ratio of 0.34 and a beta of 0.68. The company’s 50-day simple moving average is $7.43 and its two-hundred day simple moving average is $7.47. Bausch Health Companies has a 52-week low of $3.96 and a 52-week high of $11.46.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. StockNews.com raised shares of Bausch Health Companies from a “hold” rating to a “buy” rating in a research report on Friday, October 25th. Royal Bank of Canada reduced their target price on shares of Bausch Health Companies from $11.00 to $10.00 and set a “sector perform” rating for the company in a report on Thursday, January 30th. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $8.00 target price (down from $12.00) on shares of Bausch Health Companies in a report on Thursday, February 6th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $7.42.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.